Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Endocrine 1

Conditions

Leukemia, Myeloid, Acute 19Lymphoma 17Lymphoma, Large B-Cell, Diffuse 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Non-Hodgkin 14Hodgkin Disease 13Multiple Myeloma 12Lymphoma, Mantle-Cell 12Lymphoma, Follicular 12Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 11Leukemia, Lymphocytic, Chronic, B-Cell 9Glioblastoma 9Lymphoma, B-Cell, Marginal Zone 8Burkitt Lymphoma 8Brain Neoplasms 8Sezary Syndrome 7Neoplasms 7Lymphoma, T-Cell, Cutaneous 7Leukemia 7Congenital Abnormalities 7Unspecified Adult Solid Tumor, Protocol Specific 6Recurrence 6Neuroblastoma 6Mycosis Fungoides 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large-Cell, Anaplastic 6Breast Neoplasms, Male 6Sarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5

Interventions

Temozolomide 7Carboplatin 4Vincristine 3Surveys and Questionnaires 3Radiotherapy 3Magnetic Resonance Imaging 3Bevacizumab 3Vorinostat 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Etoposide 2Disulfides 2veliparib 1tozuleristide 1romidepsin 1lonafarnib 1ispinesib 1etoposide phosphate 1emvododstat 1cediranib 1Valproic Acid 1Thiotepa 1Standard of Care 1Saline Solution 1Radiosurgery 1Radiation 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Spinal Cord Neoplasms × Vorinostat × Clear all
NCT01236560 2024-02-20

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

National Cancer Institute (NCI)

Phase 2/3 Completed
101 enrolled 15 charts
CNS

Astrocytoma, Spinal Cord Neoplasms

NCT01076530 2013-05-03

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

National Cancer Institute (NCI)

Phase 1 Completed
27 enrolled
CNSEndocrine

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Paraganglioma, Extra-Adrenal, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡